menu
    • menu

    PDF presentation for RANBAXY LABORATORIES LIMITED

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients. Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharma innovator, headquartered in Tokyo, Japan. We have ground operation...
    Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients. Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharma innovator, headquartered in Tokyo, Japan. We have ground operations in 43 countries and 21 manufacturing facilities spread across 8 countries. We cover all the top 25 pharmaceutical markets of the world and have a robust presence across both developed and emerging markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RANBAXY LABORATORIES LIMITEDindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot 90, Sector 32,Gurgaon-122001 (Haryana)
    Telephone
    Telephone
    +911 -244 135 000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://ranbaxy.com
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI Worldwide, Milan

    CPhI Worldwide, Milan

    Not Confirmed

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”

    “We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”

    This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

    Impressions: 1975

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

    #SpeakPharma With Veranova
    10 Sep 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 518

    https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

    #Phispers by PHARMACOMPASS
    26 Sep 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Ami Lifesciences appoints Amit Kaptain as CEO
    Ami Lifesciences appoints Amit Kaptain as CEO

    16 Sep 2022

    // HEALTH ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/ami-lifesciences-appoints-amit-kaptain-as-ceo/94234262

    HEALTH ECONOMIC TIMES
    16 Sep 2022
    Share Share
    Sun Pharma, Ranbaxy Inc sign pact with 2 plaintiff groups to settle claims
    Sun Pharma, Ranbaxy Inc sign pact with 2 plaintiff groups to settle claims

    23 Mar 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/sun-pharma-ranbaxy-inc-sign-pact-with-2-plaintiff-groups-to-settle-claims-122032301377_1.html

    BUSINESS-STANDARD
    23 Mar 2022
    Share Share
    Sun must answer for antitrust allegations against Ranbaxy
    Sun must answer for antitrust allegations against Ranbaxy

    25 Nov 2021

    // K. Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/sun-pharma-loses-bid-to-drop-antitrust-case-against-ranbaxy-jury-trail-set-for-jan-10

    K. Dunleavy FIERCEPHARMA
    25 Nov 2021
    Share Share
    Supply disruption for esomeprazole 40mg
    Supply disruption for esomeprazole 40mg

    18 Sep 2020

    // PSNC

    https://psnc.org.uk/our-news/medicine-supply-notification-esomeprazole-40mg-iv-powder-for-solution-grunenthal-ranbaxy-tilomed/

    PSNC
    18 Sep 2020
    Share Share
    Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor
    Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor

    26 May 2020

    // LAW360

    https://www.law360.com/lifesciences/articles/1276432

    LAW360
    26 May 2020
    Share Share
    GSK sells Unilever India stake for $3.35B
    GSK sells Unilever India stake for $3.35B

    08 May 2020

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/glaxosmithkline-sells-3-35b-unilever-india-stake-unwinding-consumer-health-business

    Angus Liu FIERCE PHARMA
    08 May 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact RANBAXY LABORATORIES LIMITED and get a quotation

    RANBAXY LABORATORIES LIMITED is a supplier offers 123 products (APIs, Excipients or Intermediates).

    Find a price of Cefpodoxime Proxetil bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ofloxacin bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Clarithromycin bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Levofloxacin bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Meropenem bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Midazolam bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Rabeprazole bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Aciclovir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Atorvastatin bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefadroxil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefuroxime Axetil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cephalexin Monohydrate bulk with CEP offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cilazapril bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Clofarabine bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Doxycycline bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Doxycycline Hyclate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Enalapril Maleate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Exenatide bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Fluoxetine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Flurbiprofen bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lisinopril bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Loratadine bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Mesalazine bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Pravastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Sertraline Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tadalafil bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Valacyclovir Hydrochloride bulk with DMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of Voglibose bulk with JDMF offered by RANBAXY LABORATORIES LIMITED

    Find a price of 7-Aminodesacetoxycephalosporanic Acid bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Acitretin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Adefovir Dipivoxil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Amoxicillin Trihydrate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ampicillin Trihydrate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Atazanavir Sulfate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Atorvastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Benazepril Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Bosentan Hydrate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Candesartan Cilexetil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefaclor bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefdinir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefditoren Pivoxil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefditoren Sodium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cefprozil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cephalexin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cephradine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cilastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cilastatin Sodium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Cilostazol bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ciprofloxacin Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Citalopram Hydrobromide bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Clorazepate Dipotassium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Desloratadine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Donepezil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Duloxetine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Efavirenz bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Emtricitabine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Entacapone bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Esomeprazole Magnesium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Etodolac bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Febuxostat bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Fexofenadine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Fosamprenavir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Fosinopril bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Gabapentin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Galantamine Hydrobromide bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ganciclovir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Imipenem bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Irbesartan bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Isotretinoin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lamivudine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lansoprazole bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Levetiracetam bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lopinavir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lorazepam bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Lovastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Memantine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Meropenem bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Mevastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Milnacipran Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Nevirapine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Olanzapine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Olmesartan Medoxomil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Omeprazole Magnesium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Orlistat bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Palonosetron bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Pantoprazole Sodium bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Pioglitazone Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Quetiapine Hemifumarate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Quinapril bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ramipril bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ranitidine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Repaglinide bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ritonavir bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Simvastatin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Sodium Bicarbonate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Sodium Carbonate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Solifenacin Succinate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Stavudine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tadalafil bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tamsulosin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Telbivudine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Telmisartan bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Terfenadine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tiagabine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tolterodine Tartrate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Tretinoin bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Trospium Chloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Valganciclovir Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Valsartan bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Venlafaxine Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Zidovudine bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Ziprasidone Hydrochloride bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of Zolpidem Tartrate bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of 7-AMINO-3-CHLORO-3-CEPHEM-4-CARBOXYLIC ACID bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of 7-AMINO-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID [7-AVCA] DRUG SUBSTANCE INTERMEDIATE bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of 7-AMINO-3-[(Z)-PROPEN-1-YL]-3-CEPHEM-4-CARBOXYLIC ACID (7-APCA) bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of CEFPODOXIME ACID bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of 7-AMINO-3-CHLORO-3-CEPHEM-4-CARBONXYLIC ACID-DRUG SUBSTANCE INTERMEDIATE bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of T-3811A 05 bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of AMMONIUM SALT OF MEVINOLINIC ACID bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of BICYCLOKETONE DRUG SUBSTANCE INTERMEDIATE bulk offered by RANBAXY LABORATORIES LIMITED

    Find a price of CEFUROXIME bulk offered by RANBAXY LABORATORIES LIMITED

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search